<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Sch of Pharmacy</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2FFDC7FB-15AC-434F-B4D8-FFB6F4C52541"><gtr:id>2FFDC7FB-15AC-434F-B4D8-FFB6F4C52541</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:surname>Archer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DEE447C8-37DE-4D9C-94B3-A3CDB3C82D2E"><gtr:id>DEE447C8-37DE-4D9C-94B3-A3CDB3C82D2E</gtr:id><gtr:firstName>Morgan</gtr:firstName><gtr:otherNames>Russell</gtr:otherNames><gtr:surname>Alexander</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/869211C0-1F21-44DE-BC44-E41EBBC81413"><gtr:id>869211C0-1F21-44DE-BC44-E41EBBC81413</gtr:id><gtr:firstName>Douglas</gtr:firstName><gtr:otherNames>Graham</gtr:otherNames><gtr:surname>Dunlop</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/48ED4B90-9A10-4995-9602-13C629870E53"><gtr:id>48ED4B90-9A10-4995-9602-13C629870E53</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Hawkey</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7A228825-29AE-4056-98F4-B70F9309B430"><gtr:id>7A228825-29AE-4056-98F4-B70F9309B430</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Fawcett</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/96742227-7057-4683-AE49-6A893252696C"><gtr:id>96742227-7057-4683-AE49-6A893252696C</gtr:id><gtr:firstName>Molly</gtr:firstName><gtr:surname>Stevens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E96ECDF7-11A7-4661-8957-0C0BE70D5271"><gtr:id>E96ECDF7-11A7-4661-8957-0C0BE70D5271</gtr:id><gtr:firstName>Sandra</gtr:firstName><gtr:surname>Downes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4A2DC047-DB99-4BE7-BE2B-4BD478404BB6"><gtr:id>4A2DC047-DB99-4BE7-BE2B-4BD478404BB6</gtr:id><gtr:firstName>Alicia</gtr:firstName><gtr:surname>El Haj</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0375F088-818A-437C-9B0F-0610197366AB"><gtr:id>0375F088-818A-437C-9B0F-0610197366AB</gtr:id><gtr:firstName>Sheila</gtr:firstName><gtr:surname>MacNeil</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9ADAE0D7-4F9D-41F5-8C0A-E19BE06CA1E0"><gtr:id>9ADAE0D7-4F9D-41F5-8C0A-E19BE06CA1E0</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Oreffo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/20FEE189-39EF-41CE-9DEB-F845DA0D456C"><gtr:id>20FEE189-39EF-41CE-9DEB-F845DA0D456C</gtr:id><gtr:firstName>Felicity</gtr:firstName><gtr:otherNames>Rosamari</gtr:otherNames><gtr:surname>Rose</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DA861C90-4A94-4B47-8720-7868BD1E6CD7"><gtr:id>DA861C90-4A94-4B47-8720-7868BD1E6CD7</gtr:id><gtr:firstName>Krishnaraj</gtr:firstName><gtr:surname>Ragunath</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4A9AA458-F9A0-43EC-9726-86676F718F98"><gtr:id>4A9AA458-F9A0-43EC-9726-86676F718F98</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Shakesheff</gtr:surname><gtr:orcidId>0000-0003-3236-2439</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1701F26B-544C-4E4A-ACF9-3E5F5AD90C8E"><gtr:id>1701F26B-544C-4E4A-ACF9-3E5F5AD90C8E</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:otherNames>N</gtr:otherNames><gtr:surname>Newsome</gtr:surname><gtr:orcidId>0000-0001-6085-3652</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK026682%2F1"><gtr:id>E313D939-58B4-44CA-AB03-C11C24C703A7</gtr:id><gtr:title>Acellular Approaches for Therapeutic Delivery: UK Regenerative Medicine Platform Hub Application</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K026682/1</gtr:grantReference><gtr:abstractText>Regenerative medicine will transform human health over the next 30 years. We have the ability to create new treatments that repair damaged tissues and restore the body to its original health. Our Hub will play a role in the development of these treatments and thereby help to build a strong UK industry that makes a worldwide impact. We are particularly interested in the methods by which these new treatments are administered to patients. It is difficult to deliver a living cell as a medicine because these cells are fragile and will not form tissue if they experience adverse conditions. We will invent methods to deliver cells to the correct part of the body in an optimal state to repair tissue. Our Hub will create new materials and technologies that can be used in a very large number of future medical applications. In the first phase of our work we will design new materials that recreate the opitmal conditions for stem cells to form tissue. Next we will work with 7 teams who are directly involved in translating new scientific breakthroughs into new medicines. These teams will test our materials and help improve their design by initial studies of suitability for use in Parkinson's Disease, liver diseases, bone repair, skin wound regeneration, cartilage repair, treatments of oesophageal cancer and to assist in anterior cruciate ligament operations.

We are working with leading UK industry to ensure that our technologies can be taken forward as new products that originate in the UK but treat patients across the World.</gtr:abstractText><gtr:technicalSummary>Our Hub is concerned with the problem of how a cell or drug therapy for regenerative medicine can arrive at the site of action in an optimal state for rapid and complete tissue formation. Our approach is to design new generations of acellular matrices that create 3D environments that promote tissue formation. We propose that for cell therapies to be efficacious and reliable we must ensure that the cells arrive at the site of action with high viability, minimal physical and biological disruption and with a self-assembling niche that can host, in collaboration with local signals within the patient, spontaneous tissue formation and integration. Overarching scientific principles of these core activities are:

1. The need to mimic hierarchical structures that control cell and tissue behaviour during development and tissue function. 

2. Spatial and temporal control of molecular and mechanical stimuli. Tissue morphogenesis and repair use cascades of signalling molecules over periods of hours, days, weeks and months to control cell behaviour. These signals are interpreted by cells in the context of the local mechanical environments and the presence of co-signals (eg integrin mediated cell adhesion). 

3.A single cell therapy will encounter numerous changes in environment from manufacture to engraftment. The delivery system should be a chaperone to protect the cell or drug payload against environmental changes.

4. All delivery systems must be able to be translated into clinically and commercially viable products. Therefore, delivery goals should be achieved with the simplest solutions bearing in mind the regulatory process and the risk/benefit of the final product.</gtr:technicalSummary><gtr:potentialImpactText>During the first 4 years of the Hub we have planned for a range of early impacts across a wide range of beneficiaries. These include:

TSB Cell Therapy Catapult Centre: We will fully support the early development of the Centre by making available technologies and advise. We believe that the Catapult Centre will be very well placed for early clinical adoption and quality control issues but will need to import expertise and technologies for acellular delivery systems. We will invite the Catapult Centre to be part of our International Steering Committee and will aim to meet at least quarterly with the Centre to explore opportunities.

UK Industry: We have strong industry involvement from day 1 of our Hub and indeed this reflects the fact that all our Hub groups have collaborated with industry for many years. We will communicate openly with all industry and invite new companies into the Hub. IP discussions will need to be undertaken under CDAs. Our Open Conferences will offer new opportunities for companies to get involved and exchange ideas with other companies, clinicians and academics. We will aim to begin the translation of our technologies within the first 4 years of the Hub to enhance future regenerative medicine products

NHS and Clinicians: Our Hub and Spoke model will create opportunities for early clinical translation. Within the first 4 years we expect our first generation acellular technologies (i.e. the systems we developed before the Hub was created) to be integrated into clinical trials. Lead opportunities include anterior cruciate ligament repair and integration into bone with Newcastle and the use of GMP produced human mesenchymal stem cells in autoimmune liver diseases.

General Public and Schools: The outreach programme that we describe in our main proposal will make an impact within the first 4 years on the understanding of regenerative medicine. Using the Royal Society Summer Exhibition (subject to application) and other mechanisms that we have been committed to for many years we will engage with general public to explain, without inappropriately raising expectation, the clinical and commercial potential of the field. We believe that regenerative medicine has a special responsibility to explain science and engineering to Schoolchildren. The field is exciting due to the promise to be the major medical breakthrough of the next 50 years and also exemplifies why biology, chemistry, materials and engineering are so important to their futures. Again our outreach programme ensures impact within 4 years through a Schools programme.

International Community: We want our Hub to be the international centre for delivery systems and acellular technologies and believe that based on our current profile this is a realistic aim. We will engage on an international basis to promote the UK as a centre of excellence in all aspects of regenerative medicine and specifically in the field of our Hub. Our track records show evidence of impact in India (RCUK Science Bridge and Wellcome Trust Affordable Medicines), US (patent licenses), Europe (CE marks, product launches and clinical trials), China (Shanghai Nottingham Advanced Academy and Doctoral training programmes), Japan (joint development of delivery systems) and many others.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-09-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3944500</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BSCR and BSGCT Joint Meeting: Cell therapy for cardiovascular disease in the 21st century: a reflective and prospective update</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C35037B0-5FFC-4C27-86C5-7B04B6E94F4A</gtr:id><gtr:impact>Good summary of the current status and future direction(s) of cell-based therapies in regenerative medicine.

Nice discussions with other colleagues/researchers.</gtr:impact><gtr:outcomeId>562e440b4dc8a6.94231842</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Frontiers in Regenerative Medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C4B25D38-DB37-4805-9631-E1D1972CDB1B</gtr:id><gtr:impact>Good audience focusing on regenerative medicine; good overview of our research programme.

Nice discussions afterwards on a broad range of topics.</gtr:impact><gtr:outcomeId>562e3eb5ce6e10.56505125</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRS Fall Meeting (2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>56E18075-25F5-4001-AA77-C28BFB704BE8</gtr:id><gtr:impact>This MRS talk was delivered to a large audience, and I connected with several collaborators/researchers from across the globe.</gtr:impact><gtr:outcomeId>56d9bdeaa04711.59788276</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Joint ChemE/BME Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>43C05EDB-11F0-43EE-AE53-75D73AF968D0</gtr:id><gtr:impact>Good seminar: there were several researchers from Imperial College, with whom I could progress research further along.</gtr:impact><gtr:outcomeId>56d9bce0054f32.94014896</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Corday-Morgan Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B445AB06-43C5-4D75-A03E-11B39786C569</gtr:id><gtr:impact>This talk was an acceptance of my winning the Corday-Morgan Award.

Recognition of excellence in chemical research: Corday-Morgan Award from the Royal Society of Chemistry.</gtr:impact><gtr:outcomeId>562e418cc8f059.08866841</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GRC: Self-Assembly and Supramolecular Chemistry</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>01EAB2A9-CFF9-4D12-9304-A9252C553965</gtr:id><gtr:impact>Great assembly of world-leading scientists at this GRC: terrific discussions!

I discussed with a number of collaborators in a great setting.</gtr:impact><gtr:outcomeId>562e432e521213.24971941</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society-IBS Research Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4AF3E0D1-3D46-4797-B1AA-2F04E115D63B</gtr:id><gtr:impact>Nice conference: met several students and researchers in the field.

Good summary of the field and collaborative discussions.</gtr:impact><gtr:outcomeId>562e3f14ea8ec9.33519061</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GRC: Drug Carriers in Medicine &amp; Biology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>60E2EF20-E564-43A6-BBAC-98F867BF5418</gtr:id><gtr:impact>Great conference - lots of discussion on drug-based approaches in regenerative medicine.

Good collaborative discussions afterwards, which is usual for GRC's.</gtr:impact><gtr:outcomeId>562e3c7643b493.50020565</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SIPCD 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B04AB93A-3667-4CEF-B7E3-49A2EA5B7E9C</gtr:id><gtr:impact>SIPCD was a good conference - nice discussions with possible collaborators.

Good discussions on science and progress in the field.</gtr:impact><gtr:outcomeId>562e3dfb8028c1.03442255</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>APS Pharm Sci</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2699876E-0BA9-45D8-9665-F8B68F2C626F</gtr:id><gtr:impact>Good focus on present research in pharmaceutical sciences.

Nice discussions with students and colleagues afterwards.</gtr:impact><gtr:outcomeId>562e3cfb3449a9.22476121</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Journal of Internal Medicine (JIM) Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>09ECB091-B754-4CC1-B58A-0933E9837AF0</gtr:id><gtr:impact>This symposium was very successful in stimulating discussions with several collaborators, some new and several long-standing within Sweden.

Good discussions followed the presentation.</gtr:impact><gtr:outcomeId>569cc2d8d46686.96831391</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRS Spring Meeting and Exhibit (2015)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E079EAC2-9EB8-4971-A2CE-656D7D027506</gtr:id><gtr:impact>There were several world-leading scientists present: great collaborative discussions.

I connected again with a number of collaborators, while I met a number of good students.</gtr:impact><gtr:outcomeId>562e42b1645458.44314728</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Swedish Chemical Society Berzelius Days Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>79E2F2E1-39F1-4114-9FB6-F360B48AA2BE</gtr:id><gtr:impact>This lecture was important for reconnecting with several researchers and clinical collaborators within Sweden.</gtr:impact><gtr:outcomeId>56d9be2b2bc826.51429702</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Institute for Nanotechnology Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F07A20C-1F58-4173-9EC1-644BCF605C4A</gtr:id><gtr:impact>Talk well received - several discussions afterwards.

Met several students/possible collaborators - good discussions.</gtr:impact><gtr:outcomeId>562e3e5f468560.76529674</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2016 International Symposium on Nanobiotechnology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9960552F-842D-4D61-9A2B-21AA443D6BBF</gtr:id><gtr:impact>This symposium had an excellent focus on nanomaterials and nanotechnologies! Several terrific researchers from around the world attended.</gtr:impact><gtr:outcomeId>56d9bea1ac4c80.94807070</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EMBO Workshop &quot;Stem cell mechanobiology in development and disease&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>32B2E8B3-2873-4DF9-8CF4-78240B9A8F6F</gtr:id><gtr:impact>This was an excellent workshop, and several collaborative discussions followed this event.</gtr:impact><gtr:outcomeId>56d9bc992f4e21.38463514</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>London Polymer Network (Plenary Talk)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>29A16B13-9783-4DEC-AA0E-7775C784EF91</gtr:id><gtr:impact>This network supported good disucssions amongst several leaders within the field.

I caught up with several peers/colleagues, while I met a number of enthusiastic students.</gtr:impact><gtr:outcomeId>562e4209c5c4f5.79603898</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Nanotechnology and Medicines for Tomorrow</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1090FC0A-E351-48D9-B6A6-1E99EC050120</gtr:id><gtr:impact>Good discussions about nanomaterials and the field of nanotechnology.

There were several discussions with possible (and current) collaborators.</gtr:impact><gtr:outcomeId>562e4035c00e98.34351284</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BMES CMBE Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5457FE6D-6ABA-4025-9252-929AFBCB3817</gtr:id><gtr:impact>There were several good discussions on regenerative medicine/biomaterials afterwards.

Good feedback/input from colleagues on our field.</gtr:impact><gtr:outcomeId>562e40c2f03f67.10171071</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kavli Nanoscience Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7DCCAAF7-6404-46CE-AA31-6280F5DAA48D</gtr:id><gtr:impact>Collaborative discussions with peers/colleagues.

Discussions based on nanomaterials and materials-based approaches in regenerative medicine.</gtr:impact><gtr:outcomeId>562e3d9d301662.94983478</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fourth International Conference on Multifunctional, Hybrid and Nanomaterials</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FEA1D668-011F-40E9-AB7B-EDF8B0CADE65</gtr:id><gtr:impact>This was an exciting meeting that covered a broad range of topics in research.

Good feedback from colleagues/peers.</gtr:impact><gtr:outcomeId>562e41119da654.29549255</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>12th International Conference on Materials Chemistry</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CA4EE3BB-6957-4424-AC9D-8E5D8B1D0CE1</gtr:id><gtr:impact>There was good input/feedback afterwards, along with several fruitful discussions.

This was an exciting meeting, and the collaborative discussions were good in general.</gtr:impact><gtr:outcomeId>562e45b1a5e251.47531756</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Division of Medicine Speaker Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F0F5760B-DB59-4510-B1F8-4B2D8E7BB097</gtr:id><gtr:impact>This symposium was excellent and was attended by a good, multidisciplinary audience. I was able to re-connect with several local collaborators and discuss project ideas.</gtr:impact><gtr:outcomeId>56d9bee402c8a2.10252762</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fourth International Sympsoium Frontiers in Polymer Science</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9AB6FB84-0279-462B-9638-C837241C5AAF</gtr:id><gtr:impact>There were several good scientists in polymer scientists present - good discussions.

I met with several potential collaborators in the field.</gtr:impact><gtr:outcomeId>562e439c732292.65602249</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BSMB-BRS 3rd Joint Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0E60A836-E9E8-46A6-9FF9-A15EBBF103A6</gtr:id><gtr:impact>There were good discussions around the state of materials for applications in regenerative medicine.

I met some enthusiastic students amongst the collaborative discussions.</gtr:impact><gtr:outcomeId>562e465e315471.69421175</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>4th TERMIS World Congress</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F70281A6-19CB-48C4-A180-08804F34EEE5</gtr:id><gtr:impact>Good conference with several world-leading scientists present.

Good collaborative talks in a great environment - really positive conference!</gtr:impact><gtr:outcomeId>562e49a1418dd5.57585896</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EBI-Sanger-Cambridge PhD Symposium (eSCAMPS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3CECF8A0-8AB4-40B7-8FBC-0A1031C0DE3A</gtr:id><gtr:impact>This symposium had an excellent agenda/programme; several terrific discussions on research activities followed.</gtr:impact><gtr:outcomeId>56d9be6ce31001.40911361</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Adam Neville Lecture at the University of Dundee</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F47A04CD-8A0D-4013-961C-C541190849D2</gtr:id><gtr:impact>Great discussions afterwards with several peers.

Met some students interested in the area.</gtr:impact><gtr:outcomeId>562e445ab5a1d3.62203756</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Harvard SEAS Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5103F9B9-5431-43E7-9509-6A2C813E22FD</gtr:id><gtr:impact>This was an excellent seminar at an excellent venue. I was able to continue collaborative discussions with several world-class scientists and researchers.</gtr:impact><gtr:outcomeId>56d9bd92f3ec55.77088413</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Conference on Regenerative Biomedical Materials</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C3BAEFE8-3DB6-4020-8E6C-9B1932969A2F</gtr:id><gtr:impact>Good feedback after talk - nice discussions afterwards.

I met a good group of potential collaborators.</gtr:impact><gtr:outcomeId>562e44b88f8c20.63961069</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Australian Health and Medical Congress</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>58013929-4845-4C3D-9F62-D10D758309F4</gtr:id><gtr:impact>Good discussions on biomaterials-based approaches in regenerative medicine.

The audience was interactive and there were several good discussions afterwards.</gtr:impact><gtr:outcomeId>562e3fba1573b5.47937396</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ShanghaiTech Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA073DAA-E2B3-4D33-8184-926966C12EE4</gtr:id><gtr:impact>A good round of discussions followed afterwards.

There were several colleagues present; nice discussions within the field.</gtr:impact><gtr:outcomeId>562e450de26253.13347181</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>87000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Prof Alastair Sloan: Preventing aseptic loosening of cemented joint replacements in older adults: delivery of osteogenic molecules from PMMA bone cement to encourage bone repair and implant osseointegration</gtr:description><gtr:fundingOrg>The Dunhill Medical Trust</gtr:fundingOrg><gtr:id>0008888E-66C1-4A6F-8822-5AB4C931A3DD</gtr:id><gtr:outcomeId>58c66da271ba58.39515136</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Prof Alastair Sloan: Dentine matrix incorporation into tissue engineering scaffolds for dental tissue repair</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>13B3C356-1F32-4DF5-94F1-993B3F33F9C2</gtr:id><gtr:outcomeId>58c66ce50701d4.39741062</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>178542</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Partnership Funds via Acellular Hub (Imperial-UCL)</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:id>9E078BC8-7808-481A-A6C2-53E647863223</gtr:id><gtr:outcomeId>5626306c53b3f9.88468496</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>92435</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr Stephen Richardson: A novel regenerative therapy for intervertebral disc degeneration &amp;amp; treatment of back pain</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D4008D3E-8363-4445-BFA5-626B00C4E8E4</gtr:id><gtr:outcomeId>58c66e1b57bb76.62834126</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>118002</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Partnership Funds via Acellular Hub (Imperial-UoP)</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:id>6C0147D1-E54B-4E89-A088-B7A1A3927488</gtr:id><gtr:outcomeId>56262ff9b117d7.00179531</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>66000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Prof Alastair Sloan: Development of antimicrobial injectable gels for treatment of dental disease</gtr:description><gtr:fundingOrg>Life Sciences Research Network Wales</gtr:fundingOrg><gtr:id>5F92C8E1-D702-4C71-B458-5662244A2DBC</gtr:id><gtr:outcomeId>58c66bf8e2ca29.15409646</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>59972</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Dr James Dixon: University of Nottingham/MRC CiC &amp;quot;ImmortaSTEM: Transient Immortalisation for Human Stem Cell Expansion and Therapeutic Application&amp;quot;</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BFF97924-4B0F-4BF8-B6C0-B83B57012012</gtr:id><gtr:outcomeId>58c66b8a3f9795.08498270</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Manchester Academic Health Science Centre</gtr:department><gtr:description>Dr Stephen Richardson: A novel regenerative therapy for intervertebral disc degeneration &amp;amp; treatment of back pain</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>University of Manchester</gtr:fundingOrg><gtr:id>1D5A86C4-C3FF-410A-A630-68E53E0DD35C</gtr:id><gtr:outcomeId>58c66eeede82e1.40637606</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Prof Alastair Sloan: Liposomal Delivery of Antimicrobials for Dental cements for Dental Tissue Repair</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>33E187E5-E6FD-4FBE-8B72-68DFEEBA3C8B</gtr:id><gtr:outcomeId>58c66c65822096.38293343</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9A115AA4-1B97-46B8-A0A6-5AB1B443106D</gtr:id><gtr:title>Overcoming translational challenges - The delivery of mechanical stimuli in vivo.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81508399548ebd0582dbdbc42d52f065"><gtr:id>81508399548ebd0582dbdbc42d52f065</gtr:id><gtr:otherNames>Markides H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>585d33897d4702.67433491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BAFD994-7932-4077-863F-9D4C77BE8C15</gtr:id><gtr:title>The effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapies.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a76346a7a7bfe8d0a0fb2bba4d039ce"><gtr:id>0a76346a7a7bfe8d0a0fb2bba4d039ce</gtr:id><gtr:otherNames>Amer MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3573</gtr:issn><gtr:outcomeId>56dfef1866ae95.48255564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0111967A-0592-476F-9684-90F72210C0B1</gtr:id><gtr:title>High-resolution 3D imaging of osteocytes and computational modelling in mechanobiology: insights on bone development, ageing, health and disease</gtr:title><gtr:parentPublicationTitle>European Cells and Materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cbea385eca44b0d7135c36f7e3f233a"><gtr:id>7cbea385eca44b0d7135c36f7e3f233a</gtr:id><gtr:otherNames>Goggin P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>585d71c1a04377.04088641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DAA6E72-8F04-42A5-BD3E-9D65999BE0B6</gtr:id><gtr:title>Highly Efficient Delivery of Functional Cargoes by the Synergistic Effect of GAG Binding Motifs and Cell-Penetrating Peptides</gtr:title><gtr:parentPublicationTitle>TISSUE ENGINEERING PART A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aae105357e9e63383e86e12ddcb3bc63"><gtr:id>aae105357e9e63383e86e12ddcb3bc63</gtr:id><gtr:otherNames>Dixon J. E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1937-3341</gtr:issn><gtr:outcomeId>56dfef17ce4440.71917247</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8881929D-16CF-4D9A-87B2-A10594BC9536</gtr:id><gtr:title>Correlated Heterospectral Lipidomics for Biomolecular Profiling of Remyelination in Multiple Sclerosis.</gtr:title><gtr:parentPublicationTitle>ACS central science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c0bcd351d9d110880efb03202f71dc"><gtr:id>d7c0bcd351d9d110880efb03202f71dc</gtr:id><gtr:otherNames>Bergholt MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2374-7943</gtr:issn><gtr:outcomeId>5a678fc2af86c3.13549875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B7F09C3-B87F-40D4-85D1-86C543543B51</gtr:id><gtr:title>Pericyte Seeded Dual Peptide Scaffold with Improved Endothelialization for Vascular Graft Tissue Engineering.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/322ffb946fde83bbd1ca56c7f9a98627"><gtr:id>322ffb946fde83bbd1ca56c7f9a98627</gtr:id><gtr:otherNames>Campagnolo P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>588a22055531c1.31070299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87A9575A-B6FE-4951-B861-3DF0FCDDA3E7</gtr:id><gtr:title>Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/010c58a956d11d3bd0198f39f0953f7a"><gtr:id>010c58a956d11d3bd0198f39f0953f7a</gtr:id><gtr:otherNames>Armstrong JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn><gtr:outcomeId>588b580ac89657.30705783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31E0176F-0AB0-401F-A772-797A609F2788</gtr:id><gtr:title>Material Cues as Potent Regulators of Epigenetics and Stem Cell Function.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2238d9c3048fe5a6f87283ecc41aa7d6"><gtr:id>2238d9c3048fe5a6f87283ecc41aa7d6</gtr:id><gtr:otherNames>Crowder SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>56c7057a6f6422.66485675</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75A1D79B-25A0-4C7A-A123-423D60ED35D3</gtr:id><gtr:title>Remotely Activated Mechanotransduction via Magnetic Nanoparticles Promotes Mineralization Synergistically With Bone Morphogenetic Protein 2: Applications for Injectable Cell Therapy.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70e576116ff8c82072eff475ad8f0b8f"><gtr:id>70e576116ff8c82072eff475ad8f0b8f</gtr:id><gtr:otherNames>Henstock JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>doi_55f94b94b9e91030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8435147-DFD1-46A4-98A1-306EBFAC1AE8</gtr:id><gtr:title>Temporally degradable collagen-mimetic hydrogels tuned to chondrogenesis of human mesenchymal stem cells.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b92f4da8600ec0a5616e29af2436517d"><gtr:id>b92f4da8600ec0a5616e29af2436517d</gtr:id><gtr:otherNames>Parmar PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>585d71bb17c028.13496558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>506CBC4D-FECC-44D2-A39A-50C3328A27AE</gtr:id><gtr:title>Production of ascorbic acid releasing biomaterials for pelvic floor repair.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0839a42ed1850b8c4c1052e304e66cf5"><gtr:id>0839a42ed1850b8c4c1052e304e66cf5</gtr:id><gtr:otherNames>Mangir N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>585d71b1e868c3.47160591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>942116DF-22DB-4C4F-A50F-88F71C1C4333</gtr:id><gtr:title>Surface modification of PdlLGA microspheres with gelatine methacrylate: Evaluation of adsorption, entrapment, and oxygen plasma treatment approaches.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ec3aa64355ddbc45832aebdb2ab3496"><gtr:id>2ec3aa64355ddbc45832aebdb2ab3496</gtr:id><gtr:otherNames>Baki A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>58c6678ca4ac43.31943018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50A8970B-BB9A-4FB5-9229-88749120B026</gtr:id><gtr:title>Harnessing the Versatility of Bacterial Collagen to Improve the Chondrogenic Potential of Porous Collagen Scaffolds.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b92f4da8600ec0a5616e29af2436517d"><gtr:id>b92f4da8600ec0a5616e29af2436517d</gtr:id><gtr:otherNames>Parmar PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>585d71af89d081.25167285</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFA41988-B862-4159-9B0B-541226651CFC</gtr:id><gtr:title>Osteogenic Programming of Human Mesenchymal Stem Cells with Highly Efficient Intracellular Delivery of RUNX2.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f80f64a5f1bb5d3b9a0d07be99abc586"><gtr:id>f80f64a5f1bb5d3b9a0d07be99abc586</gtr:id><gtr:otherNames>Thiagarajan L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>5a2fda618440f0.24999900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DEE8C0A-6CDE-4B0F-B721-26F77E9F87DF</gtr:id><gtr:title>Metabolic determinants of the immune modulatory function of neural stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d27b63f32fc7fdad16e23dcc7ae4d54"><gtr:id>2d27b63f32fc7fdad16e23dcc7ae4d54</gtr:id><gtr:otherNames>Drago D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>58c6678cd77176.38931820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5835387B-544B-4679-8F56-F405CCA24090</gtr:id><gtr:title>Key elements for nourishing the translational research environment.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c3d8121c4f536b89c7af6fb56f21a90"><gtr:id>4c3d8121c4f536b89c7af6fb56f21a90</gtr:id><gtr:otherNames>Volk HD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>doi_55faa2aa25c443a7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>967BC187-FA8E-44B9-AD7C-809F4CE38A67</gtr:id><gtr:title>Skeletal stem cell and bone implant interactions are enhanced by LASER titanium modification.</gtr:title><gtr:parentPublicationTitle>Biochemical and biophysical research communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33af107609e5e6631e77d3a401bed7ca"><gtr:id>33af107609e5e6631e77d3a401bed7ca</gtr:id><gtr:otherNames>Sisti KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-291X</gtr:issn><gtr:outcomeId>585d71b7ed1df8.08918806</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB131C72-4408-445C-BB8A-0580340E4886</gtr:id><gtr:title>Raman Spectroscopy Reveals New Insights into the Zonal Organization of Native and Tissue-Engineered Articular Cartilage.</gtr:title><gtr:parentPublicationTitle>ACS central science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c0bcd351d9d110880efb03202f71dc"><gtr:id>d7c0bcd351d9d110880efb03202f71dc</gtr:id><gtr:otherNames>Bergholt MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2374-7943</gtr:issn><gtr:outcomeId>588b56828b5da6.32266330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD9F77F1-C603-4F12-90F3-0DDD7A8F42A3</gtr:id><gtr:title>NANOPARTICLE-ASSOCIATED CELL PENETRATING AND CYTOTOXIC PEPTIDES AS A NOVEL THERAPEUTIC STRATEGY FOR MALIGNANT GLIOMA</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eefb6bd86078372f318adb953cae0ce9"><gtr:id>eefb6bd86078372f318adb953cae0ce9</gtr:id><gtr:otherNames>Kelly James</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>56dfef181eb999.47604810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A843474C-E980-42F9-8A54-0AC77BD2DD66</gtr:id><gtr:title>SIMULTANEOUS INTRA-CAVITY DELIVERY OF MULTIPLE CHEMOTHERAPEUTICS FROM A MOULDABLE NEUROSURGICALLY-APPLIED POLYMER PASTE</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2b85cfc6d4e221432e56d142c7af725"><gtr:id>a2b85cfc6d4e221432e56d142c7af725</gtr:id><gtr:otherNames>Gould Toby W.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>56dfef17715e67.08100090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE1236F0-F4EF-40BE-83B6-200FCD33730F</gtr:id><gtr:title>Post-Modified Polypeptides with UCST-Type Behavior for Control of Cell Attachment in Physiological Conditions.</gtr:title><gtr:parentPublicationTitle>Materials (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37cc46bb93b84a4c422ad36a737fec3b"><gtr:id>37cc46bb93b84a4c422ad36a737fec3b</gtr:id><gtr:otherNames>Xue X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1996-1944</gtr:issn><gtr:outcomeId>5a931ba179bd94.21562191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED2E21FB-2562-47BD-8C24-5E5D11616C8A</gtr:id><gtr:title>Episomal plasmid-based generation of induced pluripotent stem cells from fetal femur-derived human mesenchymal stromal cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68d6dca49273a71ffb44e17503f8f776"><gtr:id>68d6dca49273a71ffb44e17503f8f776</gtr:id><gtr:otherNames>Megges M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>585d5477a5f638.70646405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5836786-53A1-4018-A1E5-D76FAE1AE72E</gtr:id><gtr:title>Extracellular vesicles are independent metabolic units with asparaginase activity.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50d888fdfcf8107a87022b8abbe1c357"><gtr:id>50d888fdfcf8107a87022b8abbe1c357</gtr:id><gtr:otherNames>Iraci N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>5a782bf51088a9.63491646</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7684128-8B22-44DA-94D4-F8893281B562</gtr:id><gtr:title>Preventing tissue fibrosis by local biomaterials interfacing of specific cryptic extracellular matrix information.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/444ebc9f35f9f069809453eb561871ed"><gtr:id>444ebc9f35f9f069809453eb561871ed</gtr:id><gtr:otherNames>Horejs CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a931b7037c2c0.78147484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>104281B4-8304-4CE4-9331-BE0220DEB87B</gtr:id><gtr:title>Biologically-active laminin-111 fragment that modulates the epithelial-to-mesenchymal transition in embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/444ebc9f35f9f069809453eb561871ed"><gtr:id>444ebc9f35f9f069809453eb561871ed</gtr:id><gtr:otherNames>Horejs CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_540e199e1992e2953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E99C882-BF77-40E6-BE8F-F0CEAADAF965</gtr:id><gtr:title>Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/774adde14d69c12426f5b7e4aac46b56"><gtr:id>774adde14d69c12426f5b7e4aac46b56</gtr:id><gtr:otherNames>Dixon JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>585d544cc40b62.11486451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EACD09FB-5522-43E5-A0C3-8C637F5645B0</gtr:id><gtr:title>Highly efficient intracellular transduction in three-dimensional gradients for programming cell fate.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5cd81c894057999f7ee5ff44a22d5a0"><gtr:id>e5cd81c894057999f7ee5ff44a22d5a0</gtr:id><gtr:otherNames>Eltaher HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>585d71b52a1c65.96153891</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CF72DD0-3DCC-4CE0-9AE2-A6AA49AA8463</gtr:id><gtr:title>The chorioallantoic membrane (CAM) assay for the study of human bone regeneration: a refinement animal model for tissue engineering.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4f9beba60f5eec65f9d7bcf7e10a13a"><gtr:id>a4f9beba60f5eec65f9d7bcf7e10a13a</gtr:id><gtr:otherNames>Moreno-Jim?nez I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d71be486c32.27652269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0808B86-CAE9-4106-82B0-5AD8DB01DAA0</gtr:id><gtr:title>Controlled release of GAG-binding enhanced transduction (GET) peptides for sustained and highly efficient intracellular delivery.</gtr:title><gtr:parentPublicationTitle>Acta biomaterialia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da0db2a6b80b9bf8c4d313622d8950e9"><gtr:id>da0db2a6b80b9bf8c4d313622d8950e9</gtr:id><gtr:otherNames>Abu-Awwad HAM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1742-7061</gtr:issn><gtr:outcomeId>5a931ba1b53411.39764690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19993722-CB72-4C1F-A00D-4ADCA31A1652</gtr:id><gtr:title>Changing the mindset in life sciences toward translation: a consensus.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/367106ef6f7a3b6b307e995502e57516"><gtr:id>367106ef6f7a3b6b307e995502e57516</gtr:id><gtr:otherNames>Duda GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>doi_55faa2aa25ba3672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DB099A4-3D7D-49C7-A9FB-DCA5478AA0D6</gtr:id><gtr:title>Collagen-mimetic peptide-modifiable hydrogels for articular cartilage regeneration.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b92f4da8600ec0a5616e29af2436517d"><gtr:id>b92f4da8600ec0a5616e29af2436517d</gtr:id><gtr:otherNames>Parmar PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>562517c6bfce89.16680544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>435ECED8-3BD2-4B13-BDF8-8EE2B14BA9EA</gtr:id><gtr:title>The Chorioallantoic Membrane Assay for Biomaterial Testing in Tissue Engineering: A Short-Term In Vivo Preclinical Model.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part C, Methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4f9beba60f5eec65f9d7bcf7e10a13a"><gtr:id>a4f9beba60f5eec65f9d7bcf7e10a13a</gtr:id><gtr:otherNames>Moreno-Jim?nez I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1937-3384</gtr:issn><gtr:outcomeId>5a931afbd31513.02598938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD55CA9-65C9-4FA6-AC89-6C8CAA965BF7</gtr:id><gtr:title>A Detailed Assessment of Varying Ejection Rate on Delivery Efficiency of Mesenchymal Stem Cells Using Narrow-Bore Needles.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a76346a7a7bfe8d0a0fb2bba4d039ce"><gtr:id>0a76346a7a7bfe8d0a0fb2bba4d039ce</gtr:id><gtr:otherNames>Amer MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>58c668a798f109.10766420</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2088D34B-CBDF-45C5-A426-6C8FD05C05EE</gtr:id><gtr:title>A thermoresponsive and magnetic colloid for 3D cell expansion and reconfiguration.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15e2c8f1d7895a11784c64fdc6185bbf"><gtr:id>15e2c8f1d7895a11784c64fdc6185bbf</gtr:id><gtr:otherNames>Saeed A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn><gtr:outcomeId>56dfef18d3d384.75152504</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K026682/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>